These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26879560)

  • 41. Evaluating the performance of temporal pattern discovery: new application using statins and rhabdomyolysis in OMOP databases.
    Lavallee M; Yu T; Evans L; Van Hemelrijck M; Bosco C; Golozar A; Asiimwe A
    BMC Med Inform Decis Mak; 2022 Feb; 22(1):31. PubMed ID: 35115001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A knowledge based approach for automated signal generation in pharmacovigilance.
    Henegar C; Bousquet C; Lillo-Le Louët A; Degoulet P; Jaulent MC
    Stud Health Technol Inform; 2004; 107(Pt 1):626-30. PubMed ID: 15360888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data.
    Ibrahim H; Saad A; Abdo A; Sharaf Eldin A
    J Biomed Inform; 2016 Apr; 60():294-308. PubMed ID: 26903152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Semantic distance-based creation of clusters of pharmacovigilance terms and their evaluation.
    Dupuch M; Grabar N
    J Biomed Inform; 2015 Apr; 54():174-85. PubMed ID: 25659451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility of Prioritizing Drug-Drug-Event Associations Found in Electronic Health Records.
    Banda JM; Callahan A; Winnenburg R; Strasberg HR; Cami A; Reis BY; Vilar S; Hripcsak G; Dumontier M; Shah NH
    Drug Saf; 2016 Jan; 39(1):45-57. PubMed ID: 26446143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calculating daily dose in the Observational Medical Outcomes Partnership Common Data Model.
    Burkard T; López-Güell K; Gorbachev A; Bellas L; Jödicke AM; Burn E; de Ridder M; Mosseveld M; Gratton J; Seager S; Vojinovic D; Mayer MA; Ramírez-Anguita JM; Machín AL; Oja M; Kolde R; Bonadt K; Prieto-Alhambra D; Reich C; Català M
    Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5809. PubMed ID: 38773798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of adverse drug reaction signals using an electronic health records database: Comparison of the Laboratory Extreme Abnormality Ratio (CLEAR) algorithm.
    Yoon D; Park MY; Choi NK; Park BJ; Kim JH; Park RW
    Clin Pharmacol Ther; 2012 Mar; 91(3):467-74. PubMed ID: 22237257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accessing OMOP Common Data Model Repositories with the i2b2 Webclient - Algorithm for Automatic Query Translation.
    Majeed RW; Fischer P; Günther A
    Stud Health Technol Inform; 2021 May; 278():251-259. PubMed ID: 34042902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transformation of Electronic Health Records and Questionnaire Data to OMOP CDM: A Feasibility Study Using SG_T2DM Dataset.
    Sathappan SMK; Jeon YS; Dang TK; Lim SC; Shao YM; Tai ES; Feng M
    Appl Clin Inform; 2021 Aug; 12(4):757-767. PubMed ID: 34380168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transforming French Electronic Health Records into the Observational Medical Outcome Partnership's Common Data Model: A Feasibility Study.
    Lamer A; Depas N; Doutreligne M; Parrot A; Verloop D; Defebvre MM; Ficheur G; Chazard E; Beuscart JB
    Appl Clin Inform; 2020 Jan; 11(1):13-22. PubMed ID: 31914471
    [TBL] [Abstract][Full Text] [Related]  

  • 51. OMOP CDM Can Facilitate Data-Driven Studies for Cancer Prediction: A Systematic Review.
    Ahmadi N; Peng Y; Wolfien M; Zoch M; Sedlmayr M
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233137
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multinomial modeling and an evaluation of common data-mining algorithms for identifying signals of disproportionate reporting in pharmacovigilance databases.
    Johnson K; Guo C; Gosink M; Wang V; Hauben M
    Bioinformatics; 2012 Dec; 28(23):3123-30. PubMed ID: 23064001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transforming Thyroid Cancer Diagnosis and Staging Information from Unstructured Reports to the Observational Medical Outcome Partnership Common Data Model.
    Yoo S; Yoon E; Boo D; Kim B; Kim S; Paeng JC; Yoo IR; Choi IY; Kim K; Ryoo HG; Lee SJ; Song E; Joo YH; Kim J; Lee HY
    Appl Clin Inform; 2022 May; 13(3):521-531. PubMed ID: 35705182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.
    Shalviri G; Mohammad K; Majdzadeh R; Gholami K
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1136-40. PubMed ID: 17705214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.
    Raschi E; Poluzzi E; Salvo F; Koci A; Suling M; Antoniazzi S; Perina L; Hazell L; Moretti U; Sturkenboom M; Garbe E; Pariente A; De Ponti F
    Drug Saf; 2016 Jan; 39(1):59-68. PubMed ID: 26446144
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Causality assessment in reports on adverse drug reactions. Algorithm of Spanish pharmacovigilance system].
    Aguirre C; García M
    Med Clin (Barc); 2016 Nov; 147(10):461-464. PubMed ID: 27450163
    [No Abstract]   [Full Text] [Related]  

  • 57. [Pharmacovigilance center --internal medicine interactions: A useful diagnostic tool].
    Rochoy M; Gautier S; Bordet R; Caron J; Launay D; Hachulla E; Hatron PY; Lambert M
    Rev Med Interne; 2015 Aug; 36(8):516-21. PubMed ID: 25771174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?
    Trifirò G; Coloma PM; Rijnbeek PR; Romio S; Mosseveld B; Weibel D; Bonhoeffer J; Schuemie M; van der Lei J; Sturkenboom M
    J Intern Med; 2014 Jun; 275(6):551-61. PubMed ID: 24635221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Defining a reference set to support methodological research in drug safety.
    Ryan PB; Schuemie MJ; Welebob E; Duke J; Valentine S; Hartzema AG
    Drug Saf; 2013 Oct; 36 Suppl 1():S33-47. PubMed ID: 24166222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
    Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
    Int J Evid Based Healthc; 2005 Jul; 3(6):147-67. PubMed ID: 21631747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.